United Therapeutics Corp. - SWOT Analysis

Datamonitor's United Therapeutics Corp. Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

United Therapeutics is a biotechnology company focused on the development and commercialization of therapeutic products in the areas of cardiovascular, cancer and infectious diseases. The company develops four technology platforms: Prostacyclin Analogs, Immunotherapeutic Monoclonal Antibodies, Glycobiology, and Telemedicine. The company primarily operates in the US. It is headquartered in Silver Spring, Maryland and employed 285 people as of December 2006. The company recorded revenues of $159.6 million during the fiscal year ended December 2006, an increase of 37.7% over 2005. The operating profit of the company was $29 million during fiscal year 2006, a decrease of 32.4% over 2005. The net profit was $74 million in fiscal year 2006, an increase of 13.8% over 2005.

Scope of the Report

• Provides all the crucial company information required for business and competitor intelligence needs
• Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
• Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

• Support sales activities by understanding your customers' businesses better
• Qualify prospective partners and suppliers
• Keep fully up to date on your competitors' business structure, strategy and prospects
• Obtain the most up to date company information available